Incidence and Outcome of BCR‐ABL Mutated Chronic Myeloid Leukemia Patients Who Failed to Tyrosine Kinase Inhibitors
Cancer Medicine - United Kingdom
doi 10.1002/cam4.2410
Full Text
Open PDFAbstract
Available in full text
Date
July 27, 2019
Authors
Publisher
Wiley